News from Ambrx A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 29, 2014, 12:40 ET

Ambrx and Zhejiang Hisun Pharmaceutical to Collaborate on the Development and Commercialization of Bispecifics for Cancer

 Ambrx Inc. and Zhejiang Hisun Pharmaceutical Company Ltd. (SSE Code: 600267) today announced a collaboration for the development and...

Feb 24, 2014, 09:00 ET

Sheila Gujrathi, M.D., Joins Ambrx Board of Directors

 Ambrx Inc. today announced that Sheila Gujrathi, M.D., has joined its board of directors. Dr. Gujrathi is currently the chief medical officer...

Feb 05, 2014, 09:00 ET

Ambrx Appoints Barry Greene to Board of Directors

 Ambrx Inc. today announced the appointment of Barry Greene to its board of directors. Mr. Greene has more than 20 years of experience in the...

Aug 20, 2013, 08:00 ET

Ambrx Appoints Peter Kiener, Ph.D., as Chief Scientific Officer

 Ambrx today announced the appointment of Peter Kiener, Ph.D., as chief scientific officer. Dr. Kiener brings decades of expertise in the...

Jun 17, 2013, 08:00 ET

Ambrx And Zhejiang Medicine Co. Ltd. Form Collaboration To Develop And Commercialize Ambrx's Antibody Drug Conjugate For Breast Cancer

 Ambrx and Zhejiang Medicine Co. Ltd. (ZMC) today announced that they have formed a collaboration to develop and commercialize ARX788, Ambrx's...

May 03, 2013, 08:00 ET

Ambrx Initiates Collaboration with Bristol-Myers Squibb for Discovery, Development of Next-Generation Antibody Drug Conjugates

 Ambrx today entered into a collaboration agreement with Bristol-Myers Squibb (NYSE: BMY) for the discovery and development of novel antibody...

Apr 04, 2013, 21:00 ET

Astellas and Ambrx Initiate Collaboration for Discovery and Development of Next-Generation Antibody Drug Conjugates for Oncology

 Astellas Pharma Inc. (Tokyo: 4503, "Astellas") today entered into a collaboration with Ambrx Inc. ("Ambrx") for the discovery and development...

Jan 07, 2013, 08:00 ET

Ambrx Appoints Lawson Macartney, Ph.D., DVM, Chief Executive Officer

  Ambrx today announced the appointment of Lawson Macartney, Ph.D., DVM, to president and chief executive officer of the company and a member...

Jun 18, 2012, 05:30 ET

Ambrx Collaborates with Merck to Design and Develop Biologic Drug Conjugates

 Ambrx today announced that the company has entered into a collaboration with Merck to design and develop rationally optimized biologic drug...

Jun 22, 2011, 08:00 ET

Ambrx to Present Data from Antibody Drug Conjugate Program at Upcoming Scientific Conferences

Ambrx Inc. today announced that Ho Cho, Ph.D., the company's Chief Technology Officer, will present preclinical data from the company's antibody...

May 25, 2011, 08:00 ET

Proceedings of the National Academy of Sciences Report Superiority of Human Growth Hormone Generated with Ambrx Technology

Ambrx Inc. today announced that data from a Phase 1/2 study, published online ahead of print on May 16 by Proceedings of the National Academy of...

Feb 24, 2009, 09:00 ET

Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance

Ambrx Inc, and Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced a global strategic collaboration to develop and...

Nov 13, 2008, 08:00 ET

Clinical Data Show Long-Acting Human Growth Hormone ARX201 is Safe and Well Tolerated

Long-Acting hGH Analogue Requires Only Weekly Dosing Ambrx Inc. today announced Phase I/II clinical trial data demonstrating that ARX201, the...

Nov 05, 2008, 08:00 ET

Ambrx to Present Phase I/II Clinical Data for Optimized, Long Acting Human Growth Hormone Analogue

Ambrx Inc. today announced the scheduled presentation of data from a Phase I/II clinical trial of ARX201, the company's long-acting human growth...

Dec 18, 2007, 00:00 ET

Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.

SAN DIEGO, Dec. 18 /PRNewswire/ -- Ambrx Inc. today announced that it has entered into a global, strategic collaboration with Merck & Co....

Dec 17, 2007, 00:00 ET

Ambrx Announces Drug Discovery Alliance With Eli Lilly and Company

SAN DIEGO, Dec. 17 /PRNewswire/ -- Privately held Ambrx Inc. today announced that it has entered into a collaboration with Eli Lilly and Company...

Jul 24, 2007, 01:00 ET

Ambrx Appoints Stephen Kaldor Chief Executive Officer

SAN DIEGO, July 24 /PRNewswire/ -- Ambrx, Inc., today announced the appointment of Stephen Kaldor, Ph.D., as President and Chief Executive...

Jul 24, 2006, 01:00 ET

Ambrx Secures Additional $3 Million in Series C Financing

SAN DIEGO, July 24 /PRNewswire/ -- Ambrx, Inc., announced today it has secured commitments for an additional $3 million in Series C financing....

Jul 05, 2006, 01:00 ET

Ambrx Secures $52 Million in Series C Financing

SAN DIEGO, July 5 /PRNewswire/ -- Ambrx, Inc., announced today it has secured commitments for $52 million in Series C financing from a broad,...

Jan 10, 2006, 00:00 ET

Ambrx to Present at the 24th Annual JPMorgan Healthcare Conference

LA JOLLA, Calif., Jan. 10 /PRNewswire/ -- Ambrx, Inc. today announced that Martin A. Mattingly, the Company's president and chief executive...